menu search

Notable labs closes merger transaction with vbl therapeutics

– Notable expects to initiate trading on the Nasdaq Capital Market under ticker symbol “NTBL” effective at market open on October 17 – – Agg...

October 16, 2023, 5:01 pm

Allstate stock higher on activist interest: report

Allstate Corp shares gained 4% to close at $124.92 on Monday after Trian fund Management, an activist h...

October 16, 2023, 4:54 pm

Etg: equities fall and discount expands for this solid fund

Closed-end funds are often more sensitive to market movements, through being leveraged but also their d...

October 16, 2023, 4:46 pm

Peltz's trian fund management amasses stake in allstate: report

Nelson Peltz's hedge fund Trian fund Management has amas...

October 16, 2023, 4:36 pm

Pkb: housing and construction begins to crack

Housing is in trouble and construction will be the first thing to crack. The Invesco Building & Construction ETF (PKB) is a ...

October 16, 2023, 4:29 pm

How the israel-hamas war is rippling through markets and hurting israel-focused etf

Geopolitical tensions in the Middle East are weighing on investor sentiment in the exchange-traded fund...

October 16, 2023, 3:31 pm

Grayscale bitcoin discount narrows with etf conversion seen ‘inevitable’

The world’s largest Bitcoin fund is surging faster than the cryptocurrency itself as investors antici...

October 16, 2023, 3:29 pm

What will happen if the sec does not appeal grayscale spot bitcoin etf ruling?

The financial world has been keenly following regulatory developments in the United States with Bitcoin exchange-traded ...

October 16, 2023, 3:15 pm

Chesapeake bay watershed to benefit from $9.6 million in watershed restoration grants

Grants from NFWF’s Chesapeake Bay Watershed Stewardship fund provide equitable investments in clean w...

October 16, 2023, 3:05 pm

Health care select sector fund etf: riding the healthcare boom

The Health Care Select Sector SPDR fund is an ETF that tracks the performance of the U.S. health care s...

October 16, 2023, 2:56 pm

Hartford funds launches active equity etf via mutual fund conversion

Hartford funds has added the first active equity ETF to its lineup through the conversion of an existin...

October 16, 2023, 2:07 pm

A week in the market: a focus on key data (16-20 october)

Weekly Forex forecast (16-20 October 2023). Forex technical and fundamental analysis of USD, EUR, GBP, ...

October 16, 2023, 2:01 pm

Nfts in adtech and digital art

The emergence of Non-fungible Tokens (NFTs) has caused a seismic upheaval in the worlds of digital art ...

October 16, 2023, 1:42 pm

Procter & gamble's upcoming 1q earnings should showcase strong fundamentals: analysts

Analysts are cautious about Procter & Gamble (NYSE:PG)'s upcoming fiscal 1Q earnings, but UBS is anticipating that its strong ...

October 16, 2023, 1:18 pm

Tiziana life sciences stock continues to climb; coo ‘excited' by recent results

Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares rose 8% to $0.86 in midday trading on Monday after the clinical-stage biopharmaceutical company reveale...

October 16, 2023, 1:15 pm

Focus on btc fundamentals, says edward snowden – bitcoin amsterdam

NSA whistleblower Edward Snowden says society needs to focus on the fundamentals of Bitcoin and not its...

October 16, 2023, 12:44 pm

Cathie wood-led arkk signals the bottom is in ahead of tesla earnings: this fund offers 2x leverage - axs 2x innovation etf (nasdaq:tark), ark innovation etf (arca:arkk)

Cathie Wood-led ARK Innovation ETF ARKK was trading higher on Monday, consolidating Thursday's and Friday's combined 5.34% drop, which occurred amid t...

October 16, 2023, 12:00 pm

V.f. corp.: think twice before buying the dip

V.F. Corporation has lost nearly half its value in the past year and additional caution is advised as concerns about its ...

October 16, 2023, 11:51 am

Modifi bio raises additional $4.3 million in seed funding

Financing will drive the further development of a new class of drugs targeting DNA repair defects in cancer. NEW HAVEN, Conn., Oct. 16, 2023 (GLOBE NE...

October 16, 2023, 11:00 am

Inhibikase therapeutics highlights unblinded functional analysis from the 201 trial of risvodetinib in untreated parkinson’s disease and provides update on ongoing enrollment

BOSTON and ATLANTA, Oct. 16, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceu...

October 16, 2023, 11:00 am


Search within

Pages Search Results: